FDA Approval of MS Drug Puts Ampligen Back In Play
Patient and physician outcry resulted in FDA overturning its rejection of a MS drug. Could the same thing happen with chronic fatigue syndrome and Ampligen?
The Chronic Fatigue Syndrome Community Spoke…and the FDA Listened: The FDA’s Evocative “Voice of the Patient’ Document
The Voice of the Patient document indicated that when the chronic fatigue syndrome community spoke - the FDA really listenedFDA Puts the Squeeze on Pain Drugs – Some Fibromyalgia and Chronic Fatigue Syndrome Patients To See Effects
The FDA ruling to tighten availability of hydrocodone containing pain-killers will probably cause some fibromyalgia and chronic fatigue syndrome patients to seek alternativesME/CFS Patients Call To Action: Advocates Call for FDA to Hold ‘Real’ FDA Stakeholder’s Meeting
ME/CFS Advocates call on FDA to produce FDA Stakeholders Meeting that this time produces a clear regulatory pathway for drug development.StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
